Pulmonary hypertension in patients with sarcoidosis is associated with poor prognosis, despite treatment with a targeted therapy, a new study…
Articles by Iqra Mumal, MSc
Blocking the enzyme phosphodiesterase 5 (PDE5) is a potential new therapeutic strategy to treat early pulmonary hypertension (PH) in…
Patients with a disease that causes abnormal blood vessel formation in skin, mucous membranes and some organs are at risk…
The European Patent Office has issued a notice of allowance to the biopharmaceutical company SteadyMed for its enhanced infusion-site pain…
IV delivery of stem cells to rats with pulmonary arterial hypertension (PAH) reduced the animals’ harmful lung blood vessel remodeling and…
The use of Revatio (sildenafil)Â to treat pulmonary hypertension in patients with valvular heart disease leads to worse clinical outcomes…
Actelion’s Uptravi (selexipag) delays the progression of pulmonary arterial hypertension that stems from connective tissue disease, a follow-up analysis…
Estrogen inhibitors may treat pulmonary vascular disease by correcting metabolic defects in women with pulmonary arterial hypertension (PAH), say researchers at…
A new study shows that CMR (cardiovascular magnetic resonance)Â fluoroscopy-guided heart catheterization is a safe method with an appropriate procedure time,…